» Articles » PMID: 22067198

Smoking and Risk of Incident Psoriatic Arthritis in US Women

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2011 Nov 10
PMID 22067198
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Psoriatic arthritis (PsA) is an inflammatory arthritis that is associated with psoriasis. Previous studies have found an association between smoking and psoriasis, but the association with PsA is unclear. The authors aimed to evaluate the association between smoking and the risk of incident PsA in a large cohort of women.

Methods: 94 874 participants were included from the Nurses' Health Study II over a 14-year period (1991-2005). Information on smoking was collected biennially during follow-up. The incidence of clinician-diagnosed PsA was ascertained and confirmed by self-reported questionnaires.

Results: During 1 303 970 person-years' follow-up, the authors identified 157 incident PsA cases. Among total participants, smoking was associated with an elevated risk of incident PsA. Compared with never smokers, the RR was 1.54 for past smokers (95% CI 1.06 to 2.24) and 3.13 for current smokers (95% CI 2.08 to 4.71). With increasing smoking duration or pack-years, the risk of PsA increased monotonically (p for trend <0.0001). The increase in risk was particularly significant for PsA cases with more severe phenotypes. Secondary analysis among participants developing psoriasis during the follow-up replicated the association, demonstrating an increased risk of PsA among psoriasis cases. The risk was significant for those with higher cumulative measures of smoking or PsA cases with more severe phenotypes.

Conclusion: In this study smoking was found to be associated with a risk of PsA and cumulative measures of smoking were also associated with a higher risk of PsA among women.

Citing Articles

Epidemiological trends in psoriatic arthritis: a comprehensive population-based study.

Haddad A, Elkayam P, Stein N, Feldhamer I, Cohen A, Saliba W Arthritis Res Ther. 2024; 26(1):108.

PMID: 38802958 PMC: 11129442. DOI: 10.1186/s13075-024-03339-0.


Association between sinusitis and incident rheumatic diseases: a population-based study.

Kronzer V, Davis J, Hanson A, Sparks J, Myasoedova E, Duarte-Garcia A RMD Open. 2024; 10(1).

PMID: 38388169 PMC: 10895223. DOI: 10.1136/rmdopen-2023-003622.


Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE.

Alnaqbi K, Hannawi S, Namas R, AlShehhi W, Badsha H, Al-Saleh J Int J Rheum Dis. 2022; 25(7):725-732.

PMID: 35678066 PMC: 9544782. DOI: 10.1111/1756-185X.14357.


Psoriatic arthritis in Africa.

Maharaj A, Adebajo A Clin Rheumatol. 2021; 40(9):3411-3418.

PMID: 34180027 DOI: 10.1007/s10067-021-05841-1.


Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review.

Mulder M, van Hal T, Wenink M, Koenen H, van den Hoogen F, de Jong E Arthritis Res Ther. 2021; 23(1):168.

PMID: 34127053 PMC: 8201808. DOI: 10.1186/s13075-021-02545-4.


References
1.
Tey H, Ee H, Tan A, Theng T, Wong S, Khoo S . Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol. 2010; 37(5):426-30. DOI: 10.1111/j.1346-8138.2009.00745.x. View

2.
Simonart T, Heenen M, Lejeune O . Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal. Cell Prolif. 2010; 43(3):321-5. PMC: 6496873. DOI: 10.1111/j.1365-2184.2010.00672.x. View

3.
Griffiths C, Barker J . Pathogenesis and clinical features of psoriasis. Lancet. 2007; 370(9583):263-271. DOI: 10.1016/S0140-6736(07)61128-3. View

4.
Fortes C, Mastroeni S, Leffondre K, Sampogna F, Melchi F, Mazzotti E . Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol. 2005; 141(12):1580-4. DOI: 10.1001/archderm.141.12.1580. View

5.
Pitzalis C . Skin and joint disease in psoriatic arthritis: what is the link?. Br J Rheumatol. 1998; 37(5):480-3. DOI: 10.1093/rheumatology/37.5.480. View